Making colorectal cancer screening FITTER for purpose with quantitative faecal immunochemical tests for haemoglobin (FIT)

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 11, 2013, Pages 2065-2067

  Fraser, Callum G ^a   Halloran, Stephen P ^b   Allison, James E ^c   Young, Graeme P ^d  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

CANCER MORTALITY; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; FECAL IMMUNOCHEMICAL TEST; HUMAN; IMMUNOLOGICAL PROCEDURES; MASS SCREENING; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SIGMOIDOSCOPY; STORAGE; TEST STRIP;

COLORECTAL NEOPLASMS; FECES; HEMOGLOBINS; HUMANS; MASS SCREENING;

EID: 84886714772     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0408     Document Type: Review

References (14)

1. Imperiale TF. Noninvasive screening tests for colorectal cancer. Dig Dis 2012;30(Suppl 2):16-26
2. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): An update. Am J Gastroenterol 2008;103:1541-9
3. Libby G, Brewster DH, McClements PL, Carey FA, Black RJ, Birrell J, et al. The impact of population-based faecal occult blood test screening on colorectal cancer mortality: A matched cohort study. Br J Cancer 2012;107:255-9
4. Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD. Nottingham trial of faecal occult blood testing for colorectal cancer: A 20-year follow-up Gut 2012;61:1036-40
5. Fraser CG. A future for faecal haemoglobin measurements in the medical laboratory. Ann Clin Biochem 2012;49:518-26
6. Halloran SP, Launoy G, Zappa M. Faecal occult blood testing. In: Segnan N, Patnick J, von Karsa L, editors. European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis, 1st ed. Luxembourg: International Agency for Research on Cancer, Publications Office of the European Union, 2010:103-14
7. Huang Y, Ge W, London V, Li Q, Cai S, Zhang S, et al. Diagnostic inconsistency of faecal immunochemical tests for haemoglobin in population screening of colorectal cancer. Clin Chem Lab Med 2013:51:2173-80
8. Fraser CG, Allison JE, Halloran SP, Young GP. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J Natl Cancer Inst 2012;104:610-4
9. Tao S, Seiler CM, Ronellenfitsch U, Brenner H. Comparative evaluation of nine faecal immunochemical tests for the detection of colorectal cancer. Acta Oncol 2013 Apr 25. [Epub ahead of print].
10. Fraser CG, Allison JE, Young GP, Halloran SP. Quantitation of hemoglobin improves fecal immunochemical tests for noninvasive screening. Clin Gastroenterol Hepatol 2013 Apr 13 [Epub ahead of print].
11. Raginel T, Puvinel J, Ferrand O, Bouvier V, Levillain R, Ruiz A, et al. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening. Gastroenterology 2013;144:918-25
12. Park MJ, Choi KS, Lee YK, Jun JW, Lee HY. A comparison of qualitative and quantitative fecal immunochemicaltests in the Korean national colorectal cancer screening program. Scand J Gastrol 2012;47:461-6
13. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem Lab Med 2003;41:68-73
14. Rifai N, Annesley TM, Berg JP, Brugnara C, Delvin E, Lamb EJ, et al. An appeal to medical journal editors: The need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chem Lab Med 2012;50:411-3